Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

CEBP Focus: Rural Cancer Control

Rural Disparities in Treatment-Related Financial Hardship and Adherence to Surveillance Colonoscopy in Diverse Colorectal Cancer Survivors

Jean A. McDougall, Matthew P. Banegas, Charles L. Wiggins, Vi K. Chiu, Ashwani Rajput and Anita Y. Kinney
Jean A. McDougall
1University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico.
2University of New Mexico School of Medicine, Department of Internal Medicine, Albuquerque, New Mexico.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jamcdougall@salud.unm.edu
Matthew P. Banegas
3Kaiser Permanente, Center for Health Research, Portland, Oregon.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles L. Wiggins
1University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico.
2University of New Mexico School of Medicine, Department of Internal Medicine, Albuquerque, New Mexico.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vi K. Chiu
1University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico.
2University of New Mexico School of Medicine, Department of Internal Medicine, Albuquerque, New Mexico.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashwani Rajput
1University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico.
4University of New Mexico School of Medicine, Department of Surgery, Albuquerque, New Mexico.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anita Y. Kinney
1University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico.
2University of New Mexico School of Medicine, Department of Internal Medicine, Albuquerque, New Mexico.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-17-1083 Published November 2018
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Cancer survivors increasingly report financial hardship as a consequence of the high cost of cancer care, yet the financial experience of rural cancer survivors remains largely unstudied. The purpose of this study was to investigate potential rural disparities in the likelihood of financial hardship and nonadherence to surveillance colonoscopy.

Methods: Individuals diagnosed with localized or regional colorectal cancer between 2004 and 2012 were ascertained by the population-based New Mexico Tumor Registry. Participants completed a mailed questionnaire or telephone survey about their colorectal cancer survivorship experience, including treatment-related financial hardship and receipt of surveillance colonoscopy. Multivariable logistic regression was used to estimate adjusted odds ratios (ORs) and 95% confidence intervals (CIs).

Results: Compared with urban colorectal cancer survivors (n = 168), rural colorectal cancer survivors (n = 109) were slightly older; more likely to be married (65% vs. 59%) and have an annual income <$30,000 (37% vs. 27%); and less likely to be employed (35% vs. 41%), have a college degree (28% vs. 38%), or a high level of health literacy (39% vs. 51%). Rural survivors were twice as likely as urban survivors to report treatment-related financial hardship (OR, 1.86; 95% CI, 1.06–3.28) and nonadherence to surveillance colonoscopy guidelines (OR, 2.28; 95% CI, 1.07–4.85). In addition, financial hardship was independently associated with nonadherence to surveillance colonoscopy (OR, 2.17; 95% CI, 1.01–4.85).

Conclusions: Substantial rural disparities in the likelihood of financial hardship and nonadherence to surveillance colonoscopy exist.

Impact: Treatment-related financial hardship among rural colorectal cancer survivors may negatively affect adherence to guideline-recommended follow-up care. Cancer Epidemiol Biomarkers Prev; 27(11); 1275–82. ©2018 AACR.

Introduction

Treatment-related financial hardship is increasingly understood as a negative consequence of the high cost of cancer care. Colorectal cancer survivors may be at particularly high risk of financial hardship. In a population-based study of individuals receiving adjuvant chemotherapy for colorectal cancer, Shankaran and colleagues found that 38% of patients reported at least one financial hardship. That is approximately double the overall prevalence of financial hardship estimated from a national survey of cancer survivors reported by Yabroff and colleagues (1).

Rural cancer survivors may also be disproportionately burdened by treatment-related costs given their geographic isolation, socioeconomic disparities, and limited access to care. In qualitative studies, financial hardship is a common theme among rural cancer survivors (2–5). In addition, Pisu and colleagues found that, among rural breast cancer survivors, out-of-pocket (OOP) costs represented approximately 10% of available income, with substantially higher OOP cost to income burdens observed for rural, low-income survivors (6).

Documenting the prevalence of and identifying risk factors for treatment-related financial hardship is important because of the potential negative clinical impacts among cancer survivors. Numerous studies have demonstrated associations between financial hardship and suboptimal treatment adherence, forgoing medical care, and increased mortality (7–19). Cancer survivors who report financial problems may be less likely to follow surveillance for recurrence and screening for second primary cancers (10, 20). The National Comprehensive Cancer Network (NCCN) guidelines recommend that colorectal cancer survivors undergo surveillance colonoscopy 1 year after diagnosis and every 3 to 5 years thereafter (21, 22). While individuals with lower incomes have been identified as being less likely to receive surveillance colonoscopy (23), the long-term relationship between financial hardship and nonadherence to surveillance colonoscopy is unknown. Understanding this relationship among rural colorectal cancer survivors is of particular public health importance given the recently observed 15.6% higher colorectal cancer mortality rate in rural versus metropolitan counties (24). The objective of this study was to investigate rural disparities in financial hardship and its association with nonadherence to surveillance colonoscopy among a population-based ethnically and geographically diverse sample of colorectal cancer survivors.

Materials and Methods

Study design and source of participants

We conducted a population-based, cross-sectional survey to assess colorectal cancer survivorship issues for cancer survivors in New Mexico. Participants were identified through the New Mexico Tumor Registry (NMTR), a member of the National Cancer Institute's (NCI) Surveillance Epidemiology and End Results (SEER) program of cancer registries. This study was conducted in accordance with the Belmont Report and all research was performed after approval by the Institutional Review Board of the University of New Mexico Health Sciences Center.

Study population

Males and females ages 30 to 74 years diagnosed between 2004 and 2012 in New Mexico with localized or regional cancer of the colon or rectum were eligible for participation in this study. Individuals diagnosed with a heritable colon cancer syndrome, who did not live in the United States, were mentally incompetent, or incarcerated, and those who had died prior to the mailing of the surveys in early 2015 were excluded from this study. Exclusion criteria were ascertained through NMTR records and explained in the informed consent forms. Hispanic and rural cancer survivors were oversampled from NMTR with the goal of achieving approximately equal numbers of potentially eligible subjects. Rural–Urban Commuting Area (RUCA) codes were used to classify rural residence, based on the county of residence at the time of diagnosis (25).

Survey procedures and measures

Potential study participants were mailed a self-administered questionnaire and a $2 bill as an incentive to participate. The questionnaire aimed to comprehensively assess the experience of colorectal cancer survivors in New Mexico. For patients who had not returned the questionnaire, a reminder card was sent 2 weeks later and a member of the study staff attempted to call the participant 3 weeks following the initial mailing. Eligible participants who returned the completed questionnaires were sent an additional $25 gift card. These sequential attempts at contact and financial incentives are based on evidence-based survey methods (26).

The primary outcomes in these analyses were cancer treatment-related financial hardship and nonadherence to NCCN guidelines for surveillance colonoscopy for colorectal cancer survivors (21, 22). The questionnaire used the same measures as the Medical Expenditure Panel Survey (MEPS) Experiences with Cancer Supplement to ascertain material financial hardship (27). Participants responding “yes” to any of the four material financial hardship questions (Have you, or has anyone in your family, had to borrow money or go into debt because of your cancer, its treatment, or the lasting effects of that treatment?; Did you or your family ever file for bankruptcy because of your cancer, its treatment, or the lasting effects of that treatment?; Have you or your family had to make any other kinds of financial sacrifices because of your cancer, its treatment, or the lasting effects of that treatment?; Please think about medical visits for cancer, its treatment, or the lasting effects of that treatment. Have you ever been unable to cover your share of the cost of those visits?) were classified as having experienced financial hardship. Nonadherence to the NCCN guidelines for surveillance colonoscopy was ascertained through a series of questions on whether a participant had received colonoscopies since their diagnosis and the dates of all colonoscopies. Estimated according to the time between the date of diagnosis and the date the questionnaire was completed, participants who had not received all recommended colonoscopies within the NCCN guidelines at 1, 3, 5, and 10 years after diagnosis (i.e., depending on their year of diagnosis) were classified as nonadherent.

Demographic data on race, ethnicity, primary language spoken, marital status, education, income, and employment status were self-reported based on participants' responses to the mailed questionnaire. Data on race, ethnicity, and primary language spoken was combined into a single variable to characterize participants as non-Hispanic white (NHW), English-speaking Hispanic, Spanish-speaking Hispanic, and individuals who self-identified as neither white nor Hispanic or did not report their race or ethnicity. Health literacy was assessed using a single validated measure described by Chew and colleagues that asked patients “How confident are you filling out forms yourself?” using a 5-item response scale (28, 29). Responses were then categorized into low (not at all/a little bit), medium (somewhat, quite a bit), and high (extremely) health literacy.

Additional demographic data on age, sex, and county of residence at the time of cancer diagnosis were ascertained from the NMTR records, as were clinical data on the date of diagnosis, tumor stage, and the first course of treatment. The date of diagnosis was subtracted from the date of the survey completion to obtain a variable for the time since diagnosis.

Statistical analysis

Descriptive statistics were calculated for demographic and clinical characteristics as well as for the primary outcomes of financial hardship and nonadherence to surveillance colonoscopy. Differences in the demographic and clinical characteristics between rural and urban colorectal cancer survivors were compared using Student t tests for continuous variables and Pearson χ2 tests for categorical variables. Statistical significance was assessed at the P < 0.05 level. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the unadjusted association between sociodemographic and clinical characteristics of interest and financial burden and nonadherence to surveillance colonoscopy. To avoid collinearity of variables, the pairwise Spearman rank-correlation coefficients between sociodemographic factors were estimated. Demographic and clinical characteristics that were significant at the P < 0.2 level in bivariate analysis and had a correlation of <0.7 were then entered into a multivariable model. The goodness of fit of the final multivariable models was assessed by testing the contribution and parameterization of each sociodemographic and clinical variable in the models using a likelihood ratio (LR) test. In addition, we assessed the extent to which the associations between rural residence and financial hardship varied based on our classification of the study population by ethnicity and language (NHW, English-speaking Hispanic, and Spanish-speaking Hispanic) by fitting a regression model with categorical interaction terms. The interaction model was compared with the model without interaction terms using an LR test. All statistical analyses were conducted using STATA.SE Version 14.2.

Results

We identified 924 men and women from the statewide NCI SEER NMTR, of which 855 were considered eligible for participation in this study. We were unable to contact 363 patients, and 187 contacted patients refused to participate. In addition, 26 individuals returned the survey but did not respond to the section on financial hardship and were thus excluded from this analysis. A total of 277 participants were available for this analysis, yielding a cooperation rate of 56% (calculated as the total number of participants divided by the number of individuals we were able to contact) and a response rate of 32% (calculated as the total number of participants divided by all eligible participants identified from the NMTR; Fig. 1). Compared with nonrespondents, individuals who completed the questionnaire were less likely to be classified in SEER as rural Hispanics (15% vs. 22%) and were more likely to be non-Hispanic urban residents at the time of diagnosis (34% vs. 24%).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Study participation.

Of the 277 colorectal cancer survivors in the study population, 40% (n = 109) lived in rural areas at the time of their cancer diagnosis (Table 1). Compared with urban participants, rural colorectal cancer survivors were significantly older (mean age at diagnosis of 58 vs. 56, P = 0.019). Although differences were not statistically significant, rural participants were more likely to be married (65% vs. 59%) and have an annual income <$30,000 (37% vs. 27%). In addition, rural colorectal cancer survivors were less likely to be employed (35% vs. 41%), have a college degree (28% vs. 38%), or have a high level of health literacy (39% vs. 51%). Overall, 40% (n = 111) of participants identified as Hispanic (24% primarily English-speaking and 16% primarily Spanish-speaking). The vast majority (96%) of participants reported having surgery as part of their primary treatment, while radiation and chemotherapy were reported by 23% and 43% of the study population, respectively. No differences in the primary colorectal cancer treatment received were observed between rural and urban participants.

View this table:
  • View inline
  • View popup
Table 1.

Demographic characteristics for a cohort of colorectal cancer survivors, N = 277

Treatment-related financial hardship

Treatment-related financial hardship was reported by 48% of rural participants and 41% of urban participants (Fig. 2). Twenty-six percent of rural participants and 22% of urban participants reported borrowing money or went into debt, with >50% of those individuals borrowing or accumulating debt of ≥$10,000. Four percent of rural participants and 3% of urban participants reported that they filed for bankruptcy; 25% of rural and 26% of urban participants were unable to cover the cost of medical visits; and 27% of both rural and urban participants made other financial sacrifices because of their cancer, its treatment, or the lasting effects of that treatment.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Prevalence of treatment-related financial hardship.

In the multivariable adjusted model, rural colorectal cancer survivors were nearly twice as likely (OR, 1.86; 95% CI, 1.06–3.28) as urban survivors to report treatment-related financial hardship (Table 2). In addition, age at diagnosis, health literacy, race/ethnicity, and marital status were all independently associated with financial hardship. We did not observe evidence of a statistically significant interaction between rural residence and race/ethnicity. For every 1-year increase in the age of colorectal cancer diagnosis, a 9% decrease in the likelihood of financial hardship (OR, 0.91; 95% CI, 0.88–0.95) was observed. Compared with survivors with high health literacy, those with low health literacy were 5.4 times as likely to report financial hardship (OR, 5.41; 95% CI, 1.45–20.1). Spanish-speaking Hispanic individuals were >3 times as likely to report financial burden as NHWs (OR, 3.09; 95% CI, 1.39–6.87), while no difference in the likelihood of financial burden was observed comparing English-speaking Hispanics with NHW. In addition, those who were divorced, separated, or single (OR, 1.94; 95% CI, 1.06–3.54) were nearly twice as likely to report financial burden as married participants.

View this table:
  • View inline
  • View popup
Table 2.

Patient factors associated with treatment related financial hardship

Nonadherence to surveillance colonoscopy

Overall, 16% (n = 43) of participants were nonadherent to surveillance colonoscopy guidelines. Nonadherence was highest among participants who completed the survey ≥10 years after diagnosis, whereas all 7 participants diagnosed between 1 and 2 years prior to the survey reported receiving at least one surveillance colonoscopy (Table 3). In the multivariable adjusted analysis, participants who reported treatment-related financial hardship were two times as likely to be nonadherent as participants who did not report financial hardship (OR, 2.17; 95% CI, 1.01–4.67; Table 4). Rural residents were also two times as likely to be nonadherent as urban residents (OR, 2.28; 95% CI, 1.07–4.85). Lower levels of education were significantly associated with nonadherence, with individuals reporting a high school education or less being >3.5 times as likely to be nonadherent (OR, 3.67; 95% CI, 1.30–10.3), and individuals with some college, vocational, technical, or associates degree being nearly 3 times as likely to be nonadherent (OR, 2.93; 95% CI, 1.04–8.22) than those with a college degree or higher. Finally, participants whose colorectal cancer was diagnosed at a regional stage were 50% less likely (OR, 0.48; 95% CI, 0.22–1.05) to be nonadherent than individuals with localized disease.

View this table:
  • View inline
  • View popup
Table 3.

Descriptive table of adherence to surveillance colonoscopy by time since cancer diagnosis

View this table:
  • View inline
  • View popup
Table 4.

Relationship between treatment-related financial hardship and nonadherence to surveillance colonoscopy recommendations

Discussion

In this population-based survey of diverse colorectal cancer survivors, we identified substantial rural disparities in treatment-related financial hardship and adherence to surveillance colonoscopy guidelines. The prevalence of treatment-related financial hardship among both rural (48%) and urban (41%) participants in our study was substantially higher than that reported previously. Shankaran and colleagues reported a prevalence of treatment-related financial hardship of 38% among population-based colorectal cancer survivors from the Seattle-Puget Sound SEER registry who received adjuvant chemotherapy (15). In a national study of cancer survivors by Yabroff and colleagues, using the same MEPS measures of financial hardship as we used in our study, approximately 20% of cancer survivors report treatment-related financial hardship (1).

The higher prevalence of treatment-related financial hardship in our population is likely due to the sociodemographic characteristics of the study population. Unlike the study by Shankaran and colleagues, which reflected the more affluent and primarily non-Hispanic white population of the Seattle-Puget Sound region (15), our New Mexican population was 40% Hispanic, 30% of the participants had a high school education or less, >50% were of medium or low health literacy, 31% had an annual income <$30,000 and 20% of participants were unemployed or unable to work.

Given our unique study population, we were able to identify several disparities in financial hardship and adherence to surveillance colonoscopy that have not been reported previously, including a higher likelihood of treatment-related financial hardship among Spanish-speaking Hispanics and individuals with low health literacy, as well as a strong association between education and nonadherence to surveillance colonoscopy guidelines. Cancer patients with lower health literacy often report unmet information needs (30, 31). In our study, individuals with low health literacy were 5.4 times as likely to report financial hardship than individuals reporting high health literacy. This suggests that targeted efforts to reduce OOP costs among patients with low health literacy may be warranted. Our finding that Spanish-speaking Hispanics, but not English-speaking Hispanics, have a higher likelihood of financial burden than NHWs highlights the importance of investigating the often-overlooked heterogeneity of racial and ethnic groups and should be interpreted in the historical and political context of the Southwest. Our results are in line with previous studies showing that lower income and younger age are consistent risk factors for financial burden (6, 15, 32, 33).

Our finding that rural colorectal cancer survivors are approximately twice as likely to report treatment-related financial hardship and to be nonadherent to surveillance colonoscopy guidelines is of particular importance given emerging evidence from other studies that financial hardship is associated with higher mortality (18, 19). While this cross-sectional survey should not be used to infer causation, these results support the hypothesis that financial hardship leads cancer survivors to forgo needed medical care. Nonadherence to surveillance colonoscopy was relatively uncommon among participants in this study (16%), compared with previously reported estimates ranging between 20% and 49% within 5 years of diagnosis (34–36). This may be due to selection bias if individuals who did not respond to the survey were more likely to be nonadherent to surveillance colonoscopy, leading to a lower prevalence of nonadherence in our study sample. Moreover, our results suggest that adherence to surveillance colonoscopy declines over time. Yet we observed a strong association between financial burden and nonadherence, in addition to independent associations between rural residence and education and nonadherence, controlling for time since diagnosis. Our results are consistent with Kent and colleagues who found that cancer survivors were significantly more likely to report delaying (18.3% vs. 7.4%) or forgoing overall medical care (13.8% vs. 5.0%) than those without financial problems (10). In addition, Weaver and colleagues reported that Hispanic and black cancer survivors were more likely to forego care than white survivors (16). It is highly plausible that rural cancer survivors, especially those who experience treatment-related financial burden, face substantial barriers in accessing recommended surveillance colonoscopy and that this lack of follow-up care contributes to observed rural disparities in colorectal cancer mortality (24).

The disparities in treatment-related financial hardship and adherence to surveillance colonoscopy identified in this study underscore the economic inequalities that may lead to widening socioeconomic disparities in stage-specific colorectal cancer mortality. Despite evidence that low-income, working-age colorectal cancer patients experience considerable financial hardship, there is an unmet need to understand the unique economic experience of this population. Most studies of financial burden are conducted in higher-income, insured populations (2). Moreover, the current paradigm of financial toxicity is often focused on the impact of high deductibles, copayments and coinsurance (11), and may not fully explain financial hardship among individuals experiencing financial instability prior to their cancer diagnosis. Current strategies to reduce financial hardship, including improving cost transparency, promoting patient-provider cost communication, and reducing OOP costs (7), are based primarily on the experience of higher-income, insured patients and may not be responsive to the needs of rural patients, those from racial and ethnic minority groups, or individuals of low socioeconomic position. Our results provide preliminary evidence quantifying the prevalence of financial hardship among a socioeconomically and geographically diverse, population-based sample of colorectal cancer survivors. Intervention research to mitigate treatment-related financial hardship, particularly among rural patients, underserved racial and ethnic minority groups, and individuals of low socioeconomic position, could focus on incorporating financial counseling and resources into patient navigation. In addition, continued efforts to improve the care transition for posttreatment cancer survivors and provide locally available colonoscopy surveillance may lessen the financial burden of rural cancer survivors.

The results of this study should be interpreted in the context of several important limitations. Despite using survey methods to maximize response (26), only 56% of eligible and available study subjects completed the questionnaire. Respondents were less likely to be Hispanic or from rural areas than nonrespondents which may have resulted in an underestimate of the overall prevalence of financial hardship. On the other hand, length-biased sampling, whereby individuals living the longest and thus having more time to accumulate financial burden were more likely to be sampled, may have resulted in an overestimate of financial burden. The study's cross-sectional design also presents important limitations including an inability to estimate the incidence of financial hardship or to infer causation from these results. We also did not elicit information about insurance at the time of cancer diagnosis, loss of employment, or inability to work because of colorectal cancer diagnosis or treatment. In this study, receipt of surveillance colonoscopy is ascertained by participant self-report, which should be validated in future work by confirmation in medical records or insurance claims. Finally, many of the factors investigated in this study are likely to be highly correlated with income prior to a cancer diagnosis. In our study, we did not ask about income at the time of diagnosis, and felt that controlling for income reported at the time of the questionnaire was not appropriate, as it may be a consequence of the outcome. Despite these limitations, the identification of disparities in financial hardship has the potential to advance the study of financial burden, even if they cannot be separated from the impact of income and insurance. Modifying income and insurance require complex, potentially policy driven solutions. Even if income and insurance are the root causes of the disparities identified in this study, interventions such as financial counseling, patient navigation, and colonoscopy outreach may be most effective if targeted to the literacy and language needs of the populations with the greatest likelihood of experiencing financial hardship.

The results of this study provide novel evidence of rural disparities in financial hardship and adherence to surveillance colonoscopy. Future longitudinal studies are warranted to advance knowledge of these disparities and their potential relationship to the high rural colorectal cancer mortality rate. Moreover, these findings may be of particular relevance to the development of interventions to reduce treatment-related financial hardship.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Authors' Contributions

Conception and design: J.A. McDougall, M.P. Banegas, A.Y. Kinney

Development of methodology: A.Y. Kinney

Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.): C.L. Wiggins, A.Y. Kinney

Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis): J.A. McDougall, M.P. Banegas, C.L. Wiggins

Writing, review, and/or revision of the manuscript: J.A. McDougall, M.P. Banegas, C.L. Wiggins, V.K. Chiu, A. Rajput, A.Y. Kinney

Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases): J.A. McDougall

Study supervision: A.Y. Kinney

Other(principal investigator): A.Y. Kinney

Acknowledgments

The Surface Family Trust (A. Kinney) and internal start-up funding (A. Kinney and J. McDougall) from the University of New Mexico Comprehensive Cancer Center were used to support this project. The authors are grateful for the study coordination provided by Dr. Kristina Flores.

  • Received November 21, 2017.
  • Revision received January 8, 2018.
  • Accepted March 5, 2018.
  • Published first March 28, 2018.
  • ©2018 American Association for Cancer Research.

References

  1. 1.↵
    1. Yabroff KR,
    2. Dowling EC,
    3. Guy GP Jr.,
    4. Banegas MP,
    5. Davidoff A,
    6. Han X,
    7. et al.
    Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol 2016;34:259–67.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Ko E,
    2. Zuniga ML,
    3. Palomino H,
    4. Peacher D,
    5. Watson M
    . Qualitative study of latino cancer patient perspectives on care access and continuity in a rural, U.S.–Mexico border region. J Immigr Minor Health 2017. doi: 10.1007/s10903-017-0605-5. [Epub ahead of print].
  3. 3.↵
    1. McNulty JA,
    2. Nail L
    . Cancer survivorship in rural and urban adults: a descriptive and mixed methods study. J Rural Health 2015;31:282–91.
    OpenUrl
  4. 4.↵
    1. Rutledge TL,
    2. Kano M,
    3. Guest D,
    4. Sussman A,
    5. Kinney AY
    . Optimizing endometrial cancer follow-up and survivorship care for rural and other underserved women: Patient and provider perspectives. Gynecol Oncol 2017;145:334–9.
    OpenUrl
  5. 5.↵
    1. Wenzel J,
    2. Jones RA,
    3. Klimmek R,
    4. Krumm S,
    5. Darrell LP,
    6. Song D,
    7. et al.
    Cancer support and resource needs among African American older adults. Clin J Oncol Nurs 2012;16:372–7.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Pisu M,
    2. Azuero A,
    3. Benz R,
    4. McNees P,
    5. Meneses K
    . Out-of-pocket costs and burden among rural breast cancer survivors. Cancer Med 2017;6:572–81.
    OpenUrl
  7. 7.↵
    1. Bestvina CM,
    2. Zullig LL,
    3. Rushing C,
    4. Chino F,
    5. Samsa GP,
    6. Altomare I,
    7. et al.
    Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract 2014;10:162–7.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Dusetzina SB,
    2. Winn AN,
    3. Abel GA,
    4. Huskamp HA,
    5. Keating NL
    . Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol 2014;32:306–11.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Kelley RK,
    2. Venook AP
    . Nonadherence to imatinib during an economic downturn. N Engl J Med 2010;363:596–8.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Kent EE,
    2. Forsythe LP,
    3. Yabroff KR,
    4. Weaver KE,
    5. de Moor JS,
    6. Rodriguez JL,
    7. et al.
    Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer 2013;119:3710–7.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Lee M,
    2. Salloum RG
    . Racial and ethnic disparities in cost-related medication non-adherence among cancer survivors. J Cancer Surviv 2016;10:534–44.
    OpenUrl
  12. 12.↵
    1. McDougall JA,
    2. Bennette CS,
    3. Ramsey SD,
    4. Sullivan SD
    Relationship between out-of-pocket cost and use of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia. [abstract]. In: Proceedings of the Eighth AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; Nov 13-16, 2015; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2016;25 (3 Suppl): Abstract nr A81.
  13. 13.↵
    1. Neugut AI,
    2. Subar M,
    3. Wilde ET,
    4. Stratton S,
    5. Brouse CH,
    6. Hillyer GC,
    7. et al.
    Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol 2011;29:2534–42.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Sedjo RL,
    2. Devine S
    . Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer. Breast Cancer Res Treat 2011;125:191–200.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Shankaran V,
    2. Jolly S,
    3. Blough D,
    4. Ramsey SD
    . Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol 2012;30:1608–14.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Weaver KE,
    2. Rowland JH,
    3. Bellizzi KM,
    4. Aziz NM
    . Forgoing medical care because of cost: assessing disparities in healthcare access among cancer survivors living in the United States. Cancer 2010;116:3493–504.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Zafar SY,
    2. Peppercorn JM,
    3. Schrag D,
    4. Taylor DH,
    5. Goetzinger AM,
    6. Zhong X,
    7. et al.
    The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist 2013;18:381–90.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Ramsey SD,
    2. Bansal A,
    3. Fedorenko CR,
    4. Blough DK,
    5. Overstreet KA,
    6. Shankaran V,
    7. et al.
    Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol 2016;34:980–6.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Tucker-Seeley RD,
    2. Li Y,
    3. Subramanian SV,
    4. Sorensen G
    . Financial hardship and mortality among older adults using the 1996–2004 Health and Retirement Study. Ann Epidemiol 2009;19:850–7.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Sabatino SA,
    2. Thompson TD,
    3. Richardson LC,
    4. Miller J
    . Health insurance and other factors associated with mammography surveillance among breast cancer survivors: results from a national survey. Med Care 2012;50:270–6.
    OpenUrlCrossRefPubMed
  21. 21.↵
    National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology (NCCN Guidelines) Colon Cancer. National Comprehensive Cancer Network, 2017. Available from: https://www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf
  22. 22.↵
    National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Rectal Cancer. National Comprehensive Cancer Network, 2017. Available from: https://www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf
  23. 23.↵
    1. Salz T,
    2. Weinberger M,
    3. Ayanian JZ,
    4. Brewer NT,
    5. Earle CC,
    6. Elston Lafata J,
    7. et al.
    Variation in use of surveillance colonoscopy among colorectal cancer survivors in the United States. BMC Health Serv Res 2010;10:256.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Blake KD,
    2. Moss JL,
    3. Gaysynsky A,
    4. Srinivasan S,
    5. Croyle RT
    . Making the case for investment in rural cancer control: an analysis of rural cancer incidence, mortality, and funding trends. Cancer Epidemiol Biomarkers Prev 2017;26:992–7.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Hart LG,
    2. Larson EH,
    3. Lishner DM
    . Rural definitions for health policy and research. Am J Public Health 2005;95:1149–55.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Dillman DA,
    2. Dillman DA
    . Mail and internet surveys: the tailored design method. New York: Wiley 2000.
  27. 27.↵
    1. Yabroff KR,
    2. Dowling E,
    3. Rodriguez J,
    4. Ekwueme DU,
    5. Meissner H,
    6. Soni A,
    7. et al.
    The Medical Expenditure Panel Survey (MEPS) experiences with cancer survivorship supplement. J Cancer Surviv 2012;6:407–19.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Chew LD,
    2. Griffin JM,
    3. Partin MR,
    4. Noorbaloochi S,
    5. Grill JP,
    6. Snyder A,
    7. et al.
    Validation of screening questions for limited health literacy in a large VA outpatient population. J Gen Intern Med 2008;23:561–6.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Chew LD,
    2. Bradley KA,
    3. Boyko EJ
    . Brief questions to identify patients with inadequate health literacy. Fam Med 2004;36:588–94.
    OpenUrlPubMed
  30. 30.↵
    1. Schmidt A,
    2. Kowalski C,
    3. Pfaff H,
    4. Wesselmann S,
    5. Wirtz M,
    6. Ernstmann N
    . The influence of health literacy on information needs among women newly diagnosed with breast cancer, with special reference to employment status. J Health Commun 2015;20:1177–84.
    OpenUrl
  31. 31.↵
    1. Halbach SM,
    2. Ernstmann N,
    3. Kowalski C,
    4. Pfaff H,
    5. Pförtner TK,
    6. Wesselmann S,
    7. et al.
    Unmet information needs and limited health literacy in newly diagnosed breast cancer patients over the course of cancer treatment. Patient Educ Couns 2016;99:1511–8.
    OpenUrl
  32. 32.↵
    1. Banegas MP,
    2. Guy GP Jr.,
    3. de Moor JS,
    4. Ekwueme DU,
    5. Virgo KS,
    6. Kent EE,
    7. et al.
    For working-age cancer survivors, medical debt and bankruptcy create financial hardships. Health Aff 2016;35:54–61.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Pisu M,
    2. Kenzik KM,
    3. Oster RA,
    4. Drentea P,
    5. Ashing KT,
    6. Fouad M,
    7. et al.
    Economic hardship of minority and non-minority cancer survivors 1 year after diagnosis: another long-term effect of cancer? Cancer 2015;121:1257–64.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Rulyak SJ,
    2. Mandelson MT,
    3. Brentnall TA,
    4. Rutter CM,
    5. Wagner EH
    . Clinical and sociodemographic factors associated with colon surveillance among patients with a history of colorectal cancer. Gastrointest Endosc 2004;59:239–47.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Rolnick S,
    2. Hensley Alford S,
    3. Kucera GP,
    4. Fortman K,
    5. Ulcickas Yood M,
    6. Jankowski M,
    7. et al.
    Racial and age differences in colon examination surveillance following a diagnosis of colorectal cancer. J Natl Cancer Inst Monogr 2005:96–101.
  36. 36.↵
    1. Hilsden RJ,
    2. Bryant HE,
    3. Sutherland LR,
    4. Brasher PM,
    5. Fields AL
    . A retrospective study on the use of post-operative colonoscopy following potentially curative surgery for colorectal cancer in a Canadian province. BMC Cancer 2004;4:14.
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 27 (11)
November 2018
Volume 27, Issue 11
  • Table of Contents
  • Table of Contents (PDF)
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Rural Disparities in Treatment-Related Financial Hardship and Adherence to Surveillance Colonoscopy in Diverse Colorectal Cancer Survivors
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Rural Disparities in Treatment-Related Financial Hardship and Adherence to Surveillance Colonoscopy in Diverse Colorectal Cancer Survivors
Jean A. McDougall, Matthew P. Banegas, Charles L. Wiggins, Vi K. Chiu, Ashwani Rajput and Anita Y. Kinney
Cancer Epidemiol Biomarkers Prev November 1 2018 (27) (11) 1275-1282; DOI: 10.1158/1055-9965.EPI-17-1083

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Rural Disparities in Treatment-Related Financial Hardship and Adherence to Surveillance Colonoscopy in Diverse Colorectal Cancer Survivors
Jean A. McDougall, Matthew P. Banegas, Charles L. Wiggins, Vi K. Chiu, Ashwani Rajput and Anita Y. Kinney
Cancer Epidemiol Biomarkers Prev November 1 2018 (27) (11) 1275-1282; DOI: 10.1158/1055-9965.EPI-17-1083
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Epidemiologic Opportunities in Rural Cancer Research
  • Colorectal Cancer Screening among Hispanics in a Rural Community
  • Rural Cancer Control Commentary
Show more CEBP Focus: Rural Cancer Control
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement